Glaxosmithkline Intellectual Property (NO.2) Limited
Registered as GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED. Company number 08283252. 6 payment practices reports on file, the latest for the period ending 30 June 2026, filed 22 July 2026.
23days on average to pay
- Within 30 days
- 31 to 60 days
- Over 60 days
In the reporting period from 1 January 2026 to 30 June 2026, Glaxosmithkline Intellectual Property (NO.2) Limited reported that it took an average of 23 days to pay its suppliers' invoices. It paid 75% of invoices within 30 days, 25% in 31 to 60 days and 0% after more than 60 days. It said 0% of invoices were not paid within the agreed terms.
That average is faster than 72% of the 6,220 companies whose latest report covers a period ending since May 2025. A year earlier, in the period to 30 June 2025, the average was 28 days, so it is 5 days faster now.
Average days to pay, report by report
Bars are labelled with the month the period ended. The dashed line marks 30 days.
Every report filed
| Period | Filed | Average days | Within 30 days | 31 to 60 | Over 60 | Not within terms | Source |
|---|---|---|---|---|---|---|---|
| Jan to Jun 2026 | 22 Jul 2026 | 23 | 75% | 25% | 0% | 0% | Report |
| Jul to Dec 2025 | 26 Jan 2026 | 12 | 100% | 0% | 0% | 0% | Report |
| Jan to Jun 2025 | 29 Jul 2025 | 28 | 80% | 0% | 20% | 20% | Report |
| Jul to Dec 2024 | 31 Jan 2025 | 14 | 100% | 0% | 0% | 0% | Report |
| Jan to Jun 2024 | 30 Jul 2024 | 11 | 100% | 0% | 0% | 0% | Report |
| Jul to Dec 2023 | 30 Jan 2024 | 74 | 43% | 28% | 29% | 0% | Report |
Source: the company's filings on Check payment practices. Contains public sector information licensed under the Open Government Licence v3.0. Figures are as filed. We do not change them.